Mazowieckie centrum leczenia

Otwock 05-400

0 studies enrolling now · 2 studies all time

What they study most

Relapsed/Refractory Small Cell Lung Cancer, Squamous-Cell Non-Small-Cell Lung Cancer

Studies at this site

• A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) — Running, not enrolling
• A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201) — Stopped early